These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 36577541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cholangiocarcinoma.
    Krasinskas AM.
    Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlation between KRAS gene mutations and linicopathological features of patients with intrahepatic cholangiocarcinoma.
    Wang J, Xu MX, Wang LQ, Li HY, Wang ZL, Li LJ.
    J Biol Regul Homeost Agents; 2019 Jun; 33(5):1551-1557. PubMed ID: 31635679
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The role of molecular genetic factors in the development of cholangiocellular carcinoma].
    Chulkova SV, Loginov VI, Podluzhnyi DV, Egorova AV, Syskova AY, Semichev DG, Gladilina IA, Kudashkin NE.
    Arkh Patol; 2022 Jun; 84(3):76-83. PubMed ID: 35639847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD.
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [Abstract] [Full Text] [Related]

  • 17. [Mucin hypersecreting cholangiocarcinoma].
    Jeen YM, Jin SY.
    Korean J Hepatol; 2008 Dec; 14(4):532-6. PubMed ID: 19119249
    [No Abstract] [Full Text] [Related]

  • 18. Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population.
    Pu X, Zhu L, Li F, Zheng J, Wu H, Fu Y, Chen J, Qi L.
    Pathol Res Pract; 2020 Sep; 216(9):153116. PubMed ID: 32825971
    [Abstract] [Full Text] [Related]

  • 19. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
    Putra J, de Abreu FB, Peterson JD, Pipas JM, Mody K, Amos CI, Tsongalis GJ, Suriawinata AA.
    Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
    [Abstract] [Full Text] [Related]

  • 20. Distant cutaneous metastasis preceding the diagnosis of ductal cholangiocarcinoma.
    Stergiopoulos C, Kountouras J, Kapetanakis N, Katsinelos P, Kokkali S, Tsapournas G, Zavos C, Zaramboukas T.
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):242-3. PubMed ID: 18554225
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.